Most targeted false or misleading claims that compounded GLP-1 products were equivalent to, comparable to, or generic versions of FDA-approved drugs
Do not share the pen, even if the needle is changed, to prevent cross-contamination
Novel dual incretin agent, tirzepatide (LY3298176), for the treatment of type 2 diabetes mellitus and cardiometabolic health
For mild allergic reactions, you might take an over-the-counter antihistamine like diphenhydramine
Tirzepatide induced significant improvements in estradiol, testosterone, LH, FSH, and LH/FSH ratio
Retatrutide Half-Life and Pharmacokinetics Retatrutide has a ~6-day half-life achieved through fatty acid albumin binding comparable to semaglutide (~7 days) and tirzepatide (~5 days)